Edwin Tucker
Chief Tech/Sci/R&D Officer presso JASPER THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Posizioni attive di Edwin Tucker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 12/06/2023 | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Storia della carriera di Edwin Tucker
Precedenti posizioni note di Edwin Tucker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 28/10/2019 | 01/11/2021 |
| Acerta Pharma LLC | Compliance Officer | 01/01/2015 | 01/01/2018 |
| Chief Operating Officer | 01/01/2015 | 01/01/2019 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2013 | 01/01/2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2010 | 01/01/2013 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - | - |
Formazione di Edwin Tucker
| University of Leeds | Doctorate Degree |
| University of Connecticut | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Regno Unito | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Aziende private | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
| Acerta Pharma LLC |
- Borsa valori
- Insiders
- Edwin Tucker
- Esperienza
